Chief Physician, Doctor of Medicine, Master's Supervisor at the Department of Urology, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine. Specializes in the diagnosis and treatment of urological tumors, particularly minimally invasive surgery (da Vinci robotic surgery) for kidney tumors, renal pelvic tumors, ureteral tumors, and adrenal tumors, as well as drug therapy for advanced tumors. With over 20 years of clinical experience in urological diseases, focusing on clinical and basic research of kidney tumors, ureteral tumors, and adrenal tumors. Skilled in da Vinci robotic nephron-sparing surgery for kidney tumors (including renal angiomyolipoma), conventional laparoscopic minimally invasive nephron-sparing surgery (particularly for complex kidney tumors, bilateral kidney tumors, VHL-related renal cell carcinoma, and multiple tumors), and minimally invasive surgery for renal pelvic tumors, ureteral tumors, and adrenal tumors. In recent years, treating approximately 3,500 patients annually and independently performing nearly 400 surgeries per year for renal cell carcinoma, renal pelvic carcinoma, ureteral carcinoma, and adrenal tumors, accumulating rich clinical experience, with unique insights and experience in the diagnosis and treatment of renal cell carcinoma patients under 46 years old and rare types of renal cell carcinoma (including VHL-related renal cell carcinoma and FH-deficient renal cell carcinoma). In recent years, published over 20 SCI papers in international English journals such as Journal of Clinical Oncology, European Urology, and Journal of Urology. Awarded First Prize of Shanghai Medical Science and Technology Progress Award (second contributor), First Prize of Science and Technology Award of the Ministry of Education (second contributor), and Second Prize of Huaxia Medical Science and Technology Award (second contributor).